State of Wisconsin Investment Board
IOVA icon

State of Wisconsin Investment Board’s Iovance Biotherapeutics IOVA Stock Holding History

State of Wisconsin Investment Board’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$387K Buy
110,217
+220
+0.2% +$704 ﹤0.01% 2123
2025
Q4 		$300K Sell
109,997
-5,041
-4% -$11.7K ﹤0.01% 2168
2025
Q3 		$250K Buy
115,038
+7,079
+7% +$16.7K ﹤0.01% 2188
2025
Q2 		$186K Sell
107,959
-112,800
-51% -$281K ﹤0.01% 2210
2025
Q1 		$735K Sell
220,759
-6,075
-3% -$31.3K ﹤0.01% 1606
2024
Q4 		$1.68M Buy
226,834
+53,179
+31% +$493K ﹤0.01% 1351
2024
Q3 		$1.63M Sell
173,655
-62,714
-27% -$594K ﹤0.01% 1392
2024
Q2 		$1.9M Buy
236,369
+77,089
+48% +$826K 0.01% 1307
2024
Q1 		$2.36M Sell
159,280
-418
-0.3% -$4.87K 0.01% 1194
2023
Q4 		$1.3M Sell
159,698
-6,162
-4% -$32.2K ﹤0.01% 1326
2023
Q3 		$755K Buy
165,860
+516
+0.3% +$3.37K ﹤0.01% 1502
2023
Q2 		$1.16M Buy
165,344
+58,522
+55% +$419K ﹤0.01% 1418
2023
Q1 		$653K Sell
106,822
-12,040
-10% -$83.1K ﹤0.01% 1726
2022
Q4 		$760K Sell
118,862
-7,245
-6% -$56.6K ﹤0.01% 1669
2022
Q3 		$1.21M Sell
126,107
-7,931
-6% -$91.5K ﹤0.01% 1470
2022
Q2 		$1.48M Buy
134,038
+20,999
+19% +$275K ﹤0.01% 1452
2022
Q1 		$1.88M Buy
113,039
+95,130
+531% +$1.47M ﹤0.01% 1515
2021
Q4 		$342K Sell
17,909
-554
-3% -$12.2K ﹤0.01% 1851
2021
Q3 		$455K Buy
18,463
+1,121
+6% +$26.4K ﹤0.01% 1724
2021
Q2 		$451K Sell
17,342
-133
-0.8% -$3.46K ﹤0.01% 1711
2021
Q1 		$553K Sell
17,475
-245
-1% -$10.2K ﹤0.01% 1568
2020
Q4 		$822K Sell
17,720
-750
-4% -$29.8K ﹤0.01% 1379
2020
Q3 		$608K Buy
18,470
+690
+4% +$21.2K ﹤0.01% 1412
2020
Q2 		$488K Sell
17,780
-163,020
-90% -$5.36M ﹤0.01% 1439
2020
Q1 		$5.41M Buy
180,800
+9,300
+5% +$247K 0.02% 750
2019
Q4 		$4.75M Hold
171,500
– – 0.01% 950
2019
Q3 		$3.12M Buy
171,500
+23,100
+16% +$511K 0.01% 928
2019
Q2 		$3.64M Buy
148,400
+3,300
+2% +$49.7K 0.01% 893
2019
Q1 		$1.38M Buy
145,100
+60,200
+71% +$585K ﹤0.01% 1075
2018
Q4 		$751K Buy
84,900
+1,200
+1% +$11.6K ﹤0.01% 1208
2018
Q3 		$942K Hold
83,700
– – ﹤0.01% 1234
2018
Q2 		$1.07M Buy
83,700
+8,700
+12% +$127K ﹤0.01% 1151
2018
Q1 		$1.27M Buy
75,000
+36,000
+92% +$545K ﹤0.01% 1054
2017
Q4 		$312K Hold
39,000
– – ﹤0.01% 1358
2017
Q3 		$302K Hold
39,000
– – ﹤0.01% 1371
2017
Q2 		$287K Buy
+39,000
New +$248K ﹤0.01% 1371

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

State of Wisconsin Investment Board's IOVA Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Iovance Biotherapeutics (IOVA) stake by 0.2% in Q1 2026, buying an estimated $704 and bringing the position to 110,217 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

State of Wisconsin Investment Board first reported a position in IOVA in Q2 2017 and has held it in 36 quarters since. The position peaked at $5.41M in Q1 2020. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • State of Wisconsin Investment Board held 110,217 shares of Iovance Biotherapeutics worth $387K as of Q1 2026.
  • State of Wisconsin Investment Board bought 220 Iovance Biotherapeutics shares in Q1 2026, an estimated $704.
  • Iovance Biotherapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2123 holding.
  • State of Wisconsin Investment Board first reported a position in Iovance Biotherapeutics in Q2 2017 and has held it in 36 quarters since.
  • State of Wisconsin Investment Board's Iovance Biotherapeutics position peaked at $5.41M in Q1 2020.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.